TOP REASONS TO CONDUCT YOUR CLINICAL TRIALS IN POLAND
  
 Poland is an EU Member State (since 1 May 2004) and conducts clinical trials under EU requirements and ICH-GCP. 
 Clinical trial applications in the EU are submitted via the Clinical Trials Information System (CTIS), which became the single entry point under the EU Clinical Trials Regulation framework. 
 The EU clinical trial authorization timeline is set at 60 days (with defined review steps under the Regulation). 
 Regulatory oversight and inspections are performed by the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL). 
 Most hospitals are well-equipped, with experienced investigators and study teams, supporting efficient site set-up and high-quality trial conduct.
 Strong recruitment potential across multiple therapeutic areas, with access to large urban and regional patient pools.